Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

"The launch of LEQSELVI in the U.S. brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them," said Richard Ascroft, CEO, ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...

The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

New study in Stem Cell Research & Therapy reveals biological pathways behind hair loss, potential new treatments.

Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.

A genetic component is likely, but the traditional use of hot combs, chemical relaxers, and excessive tensions from braids ...

Fiancé star reveals a chronic health condition that impacts her appearance, sparking concern among fans who say it “looks so ...

You’ve had straight hair your whole life. It dried flat, fell neatly without effort, and never held a curl unless you forced ...